TrialThoracic cancer2023

A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer.

Yue Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.